Rotterdam

• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 5 Locally Advanced or Metastatic Cholangiocarcinoma
• SAFEST Not authorised
  2022-502059-79-00 6 Ischemic stroke or transient ischemic attack
• Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Not authorised
  2022-502968-20-01 4 Idiopathic Inflammatory Myopathies
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI … Not authorised
  2024-514693-47-00 11 EGFR mutated locally advanced or metastatic non-small cell lung cancer
• A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with … Not authorised
  2024-515199-10-00 4 Retinitis Pigmentosa
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 5 Ulcerative colitis
• A study to assess the long-term safety and clinical activity of mRNA-3927 in participants previously enrolled in the mRNA-3927-P101 study Pending
  2022-502911-12-00 9 Propionic Acidemia
• Oxytocine and migraine Pending
  2023-504690-21-00 3 This is a study in healthy volunteers. We will study the trigeminovas
• The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse gliom … Pending
  2023-504696-24-00 7 Glioma (diffuse astrocytoma, oligodendroglioma or glioblastoma)
• Iron Infusion in Elderly Patients undergoing Transcatheter Aortic Valve Implantation (IRON TAVI) Trial Pending
  2023-505095-29-03 6 Patients with Aortic stenosis and Iron deficiency
• A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE … Pending
  2023-506982-73-00 4 high risk or poor response after chemoradiation and brachytherapy for
• Optimizing subcutaneous FEntanyl titRation: RApid achievement of adequate exposure when treating cancer-Related paIn (FERRARI-study). Pending
  2023-507355-30-00 6 Cancer pain
• Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemo … Pending
  2023-508658-24-00 4 type B3 thymoma and thymic carcinoma
• RATE: Reduced anticoagulation targets in extracorporeal life support Pending
  2023-509675-16-01 5 All patients who receive ECMO treatment during the study period in one
• Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Pending
  2024-510617-15-00 5 Non-metastatic resectable pancreatic cancer
• Statins to Prevent Immune checkpoint inhibitor-induced pRogression of AtheroscLerosis Pending
  2024-511127-33-00 6 Atherosclerosis
• Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formula … Pending
  2024-511585-36-00 6 pediatric kidney transplant recipients
• A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l … Pending
  2024-512195-35-00 5 Stage I adenocarcinoma non-small cell lung cancer (NSCLC) with ctDNA-p
• Neo-adjuvant intraperitoneal chemotherapy (irinotecan) and systemic chemotherapy (mFOLFOX4-bevacizumab) prior to CRS-HIPEC for patients with … Pending
  2024-512318-16-00 4 Patients with colorectal peritoneal metastases with a PCI-score of 1-2
• COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study Pending
  2024-512350-17-01 6 Patients with coronary artery disease and an indication for PCI
• Guided by Light: Optimizing Surgical Excision of Oral Cancer Using Realtime Fluorescence Imaging Pending
  2024-512824-13-01 7 Oral cancer
• Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco … Pending
  2024-512850-10-00 5 Resectable colorectal rectal metastases without extrahepatic disease
• Avelumab Short Maintenance Trial Pending
  2024-512975-11-01 11 urothelial cancer
• TACmono LT Pending
  2024-513394-42-01 11 Vaccination response

Showing 1–24 of 818 trials